Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
This year, for World Patient Safety Day the World Health Organization (WHO) has chosen the theme “Improving Diagnosis for Pat…
Very warm weather can make it difficult to keep medicines at the temperature they need to be. Get tips for proper storage.
The goal is to keep what you need at hand and know how to access it, but medical record organization can be challenging in a …
The JNC, celebrating its 22nd year, hosts children and teens in the bleeding disorders community for a weekend full of sports…
Feeling burned out from managing a chronic medical condition? We asked five experts for their advice on recognizing burnout a…
Getting diagnosed with a serious condition can cause a sense of loss. A psychotherapist – and fellow primary immune deficienc…
We recognize physicians and the demands of continuous learning – especially when treating patients who have rare conditions. …
CSL is a member of PALADIN, a one-of-a-kind consortium that’s bringing together industry leaders and patient advocacy groups.…
Eleven CSL employees spent 24 hours immersed in the daily reality of being an asthma patient. The experience was an introduct…
We asked the leaders of patient advocacy groups – and CSL staff – to explain why rare conditions deserve attention and recogn…
CSL recently joined the nonprofit organization to strengthen patient engagement in Europe. EUPATI educates and supports patie…
Thanks to patient advisory boards, CSL is continuously learning how to partner with patients and make clinical trials less bu…
Americas
Asia Pacific
Middle East
Europe
